Literature DB >> 9369332

Activation of locus coeruleus by prefrontal cortex is mediated by excitatory amino acid inputs.

E Jodo1, G Aston-Jones.   

Abstract

We examined the role of excitatory amino acids (EAAs) in activation of noradrenergic locus coeruleus (LC) neurons evoked by electrical stimulation of the medial prefrontal cortex (mPFC) in halothane-anesthetized rats. Microinfusion of the specific N-methyl-D-aspartate antagonist 2-amino-5-phosphonopentanoic acid (AP5, 50 or 100 microM) into the LC significantly suppressed LC responses evoked by mPFC stimulation. Microinfusion of the selective non-NMDA antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 25 or 50 microM) also significantly reduced evoked LC responses. Simultaneous microinfusion of both AP5 and CNQX considerably increased the proportion of LC neurons which exhibited complete suppression of evoked responses (81%), compared to either AP5 or CNQX alone (approximately 50% each). These results indicate that LC activation by mPFC stimulation is mediated by both NMDA- and non-NMDA-type EAA channels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9369332     DOI: 10.1016/s0006-8993(97)00703-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  32 in total

1.  The influence of spike rate and stimulus duration on noradrenergic neurons.

Authors:  Eric Brown; Jeff Moehlis; Philip Holmes; Ed Clayton; Janusz Rajkowski; Gary Aston-Jones
Journal:  J Comput Neurosci       Date:  2004 Jul-Aug       Impact factor: 1.621

2.  3-Monoiodothyronamine: the rationale for its action as an endogenous adrenergic-blocking neuromodulator.

Authors:  Heinrich S Gompf; Joel H Greenberg; Gary Aston-Jones; Alexandra G Ianculescu; Tom S Scanlan; Mary B Dratman
Journal:  Brain Res       Date:  2010-07-23       Impact factor: 3.252

3.  α₂- and β-adrenoceptors involvement in nortriptyline modulation of auditory sustained attention and impulsivity.

Authors:  Swagata Roychowdhury; Zulma Peña-Contreras; Jason Tam; Amulya Yadlapalli; Lu Dinh; Justin Andrew Nichols; Debarshi Basu; Marco Atzori
Journal:  Psychopharmacology (Berl)       Date:  2012-01-21       Impact factor: 4.530

Review 4.  Rate-dependent behavioral effects of stimulation of central motoric alpha(1)-adrenoceptors: hypothesized relation to depolarization blockade.

Authors:  Eric A Stone; David Quartermain
Journal:  Psychopharmacology (Berl)       Date:  2005-01-12       Impact factor: 4.530

5.  Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity.

Authors:  Heinrich S Gompf; Gary Aston-Jones
Journal:  Brain Res       Date:  2008-06-03       Impact factor: 3.252

6.  Designer receptor manipulations reveal a role of the locus coeruleus noradrenergic system in isoflurane general anesthesia.

Authors:  Elena M Vazey; Gary Aston-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

Review 7.  New developments and future directions in understanding locus coeruleus - Norepinephrine (LC-NE) function.

Authors:  Stephen L Foote; Craig W Berridge
Journal:  Brain Res       Date:  2018-09-26       Impact factor: 3.252

8.  Glutamate receptor subunit expression in the rhesus macaque locus coeruleus.

Authors:  Nigel C Noriega; Vasilios T Garyfallou; Steven G Kohama; Henryk F Urbanski
Journal:  Brain Res       Date:  2007-08-09       Impact factor: 3.252

9.  Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression.

Authors:  R Bernard; I A Kerman; R C Thompson; E G Jones; W E Bunney; J D Barchas; A F Schatzberg; R M Myers; H Akil; S J Watson
Journal:  Mol Psychiatry       Date:  2010-04-13       Impact factor: 15.992

10.  Increased noradrenaline levels in the rostral pons can be reversed by M1 antagonist in a rat model of post-traumatic stress disorder.

Authors:  Berna Terzioğlu; Melisa Kaleli; Banu Aydın; Sema Ketenci; Hülya Cabadak; M Zafer Gören
Journal:  Neurochem Res       Date:  2013-05-17       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.